Michigan Automated Prescription System (MAPS), May 2020 Data (ICPSR 37833)
Version Date: Sep 2, 2020 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Michigan. Department of Licensing and Regulatory Affairs
https://doi.org/10.3886/ICPSR37833.v1
Version V1
These data are unavailable indefinitely from ICPSR.
Summary View help for Summary
More complete MAPS data, including the May 2020 data, are now available via ICPSR instead of NAHDAP. Please visit the ICPSR website to apply for access to these data: Michigan Automated Prescription System (MAPS), January 2014-August 2020 Data (ICPSR 37887).
Michigan Automated Prescription System (MAPS) is Michigan's prescription monitoring program used to track controlled substances and Schedule 2-5 drugs. Prescribers, dispensers, and practitioners use the tool to assess patient risk and analyze controlled substance use history. They obtain information on controlled substances and Schedule 2-5 drugs that have been dispensed. The portal is also used to prevent drug abuse and diversion at the prescriber, pharmacy, and patient levels.
The MAPS portal is administered by the Michigan Department of Licensing and Regulatory Affairs and maintained by Appriss Health. Gov. Rick Snyder formed the Michigan Prescription Drug and Opioid Abuse Task Force in June 2015 and one of their key recommendations was to update and replace the former MAPS platform. The governor also established the Prescription Drug and Opioid Abuse Commission to continue the work initiated by the task force. In addition to the new system and the work of the commission, the Snyder Administration along with a group of bipartisan legislators focused on building on the state's aim to tackle the opioid crisis.
This study is the May 2020 upload of the MAPS data.
Citation View help for Citation
Export Citation:
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Smallest Geographic Unit View help for Smallest Geographic Unit
City
Restrictions View help for Restrictions
Access to these data is restricted. Users interested in obtaining these data must complete a Restricted Data Use Agreement, specify the reason for the request, and obtain IRB approval or notice of exemption for their research.
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Data Collection Notes View help for Data Collection Notes
- For general information about the data, visit the Michigan LARA website.
- The law that covers MAPS is available to view on the Michigan Legislature website.
- In order to comply with the State of Michigan's request to delete these data, this study has been deaccessioned. For general information, visit the Michigan LARA website.
Study Purpose View help for Study Purpose
According to the Michigan Department of Health and Human Services website: "Michigan has a tool that helps prescribers identify patients that may be improperly seeking medication. This is Michigan's prescription drug monitoring program called the Michigan Automated Prescription System (MAPS). MAPS is used to identify and prevent drug diversion at the prescriber, pharmacy, and patient level."
Unit(s) of Observation View help for Unit(s) of Observation
Data Source View help for Data Source
Michigan Automated Prescription System (MAPS)
Data Type(s) View help for Data Type(s)
HideOriginal Release Date View help for Original Release Date
2020-09-02
Version History View help for Version History
2020-09-02 ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:
- Checked for undocumented or out-of-range codes.